エピソード

  • Ozempic and the Food Industry — Who's Losing? - Follow the money with Nick Ledger

    Ozempic and the Food Industry — Who's Losing? - Follow the money with Nick Ledger
    2026/04/07
    When millions of Americans on Ozempic stop craving snacks, sodas, and second helpings, entire industries face ruin. Host Nick Ledger traces the money through grocery aisles, fast food chains, and bar tabs to reveal which companies are hemorrhaging billions as appetite-suppressing drugs rewrite the American food economy. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
    続きを読む 一部表示
    1 分
  • Ozempic and the Food Industry — Who's Losing? - The Drive-Thru Slowdown

    Ozempic and the Food Industry — Who's Losing? - The Drive-Thru Slowdown
    2026/04/07
    Nick Ledger examines how GLP-1 weight loss medications are disrupting America's fast-food industry, with spending at drive-thrus dropping 8% as users consume fewer calories and crave nutrient-dense foods over burgers and fries. We discuss reported shifts in consumer behavior and the economic ripple effects reshaping restaurants, suppliers, and communities nationwide. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
    続きを読む 一部表示
    27 分
  • Ozempic and the Food Industry — Who's Losing? - Last Call for the Bar Tab

    Ozempic and the Food Industry — Who's Losing? - Last Call for the Bar Tab
    2026/04/07
    Nick Ledger examines how GLP-1 drugs like Ozempic are reshaping America's alcohol industry. Clinical studies show users reduce drinking by up to 66%, not through willpower but neurochemical changes that eliminate cravings. From craft breweries to dive bars, businesses built on repeat consumption face an unprecedented challenge as their highest-margin product becomes biologically unnecessary. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
    続きを読む 一部表示
    22 分
  • Ozempic and the Food Industry — Who's Losing? - The Snack Aisle Apocalypse

    Ozempic and the Food Industry — Who's Losing? - The Snack Aisle Apocalypse
    2026/04/07
    Nick Ledger examines how GLP-1 medications are reshaping America's food economy as millions of users reduce calorie intake by 700-1,000 daily. The episode explores grocery spending declines, corporate pivots like Mars' $800M acquisition, and the fundamental challenge to an industry built on endless appetite. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
    続きを読む 一部表示
    18 分